{"name":"Shanghai Shengdi Pharmaceutical Co., Ltd","slug":"shanghai-shengdi-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"Shanghai Shengdi Pharmaceutical Co., Ltd is a pharmaceutical company focused on the development and commercialization of innovative drugs. The company has a diverse pipeline with several drugs in various stages of clinical trials, including Gadobutrol Injection, SHR-4610 Injection, and Camrelizumab + Pemetrexed + Carboplatin.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Gadobutrol Injection","genericName":"Gadobutrol Injection","slug":"gadobutrol-injection","indication":"MRI contrast enhancement for diagnostic imaging of the central nervous system, body, and cardiovascular system","status":"phase_3"}]}],"pipeline":[{"name":"Gadobutrol Injection","genericName":"Gadobutrol Injection","slug":"gadobutrol-injection","phase":"phase_3","mechanism":"Gadobutrol is a gadolinium-based contrast agent that accumulates in tissues and enhances magnetic resonance imaging (MRI) signal by shortening T1 relaxation time.","indications":["MRI contrast enhancement for diagnostic imaging of the central nervous system, body, and cardiovascular system"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxOUUFZMDF4Nm1WZWZ0NHVxQWZkUUo5WFZNT2RwUXZCYUpQSTdfYWRUMjk2Z3RKbE5vam1yX2JIYWk1NjhTcFhKWTR1TWMxcXpURkc5NC1BNVJBamRpZVJvRHUwWUFjeS1wV3YzbFpiUDB5MDB2bmtxMkVFSVlpLW13QkpNM2xqTXBaVmdXUHVXczN1aGRiZlhlNkRFdmF5TVpvSDdmOWxOQ0g4TmJyRDdDUnpkTjB3OWY1XzNPa1lNOEhQSWp2QlpQSzg4bkJWWjFac0RFWVdOdWZmd2k1?oc=5","date":"2026-03-25","type":"pipeline","source":"TipRanks","summary":"Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase - TipRanks","headline":"Jiangsu Hengrui Boosts Investment in Shanghai Regenelead via RMB750 Million Capital Increase","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOdWJEZHA1ZVp5SGJ6SmNoNmJZcndMbGhFckVJM2hJZUpxSjZoU1Y0QXViQWZNM3ZRY0t1UzlSVTJFejZLWHFFNm5JRHBZSGR0NWhUbWlwWF9hN0VrOEcwSmJkX0xlRGVEUVROTEVUckR3SVFtYUVGa2tKb3dodzZBeGpnRm90cGZ3MEVTaGFyNHQ2aUNENzVBZGxGR2MxT2lFU2RGY3VYZmhtWTNfdHcyWHh2RWJGeEMway1jaVBhSU9vMDRDMHRQV3Bzb3FLZWlTVHJsYm9SLXF3elhEek1uUXFZNA?oc=5","date":"2026-03-24","type":"pipeline","source":"marketscreener.com","summary":"Shanghai Ruihongdi Pharmaceutical Co., Ltd. announced that it expects to receive CNY 750 million in funding from Shanghai Shengdi Private Equity Fund Management Co., Ltd., Shenzhen Yingtai Asset Manag","headline":"Shanghai Ruihongdi Pharmaceutical Co., Ltd. announced that it expects to receive CNY 750 million in funding from Shangha","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxOcWhBNnBiVFF2WlZNbzRtbzNhUW5RUXQ5WkZsa1BjYk5QNHZPNk1JMG56MlRuckVLVUFseTZLbDhOczQyQ3JTT1p2R096aVE1V0xxWjNKd011MTJzcndTa0tVVFRnSkt0RGk0MWxxMXNuYW50THJ1SFNRWE9TdmxLZnF2UmVMVmRUSWlwSWhBMHd1emNGV2kxSDVLMW5NOWZJYS1qRG5WNmd2MVNvdG9sVjVB?oc=5","date":"2025-11-07","type":"pipeline","source":"富途牛牛","summary":"Breaking: Directors and Senior Executives of Solid-State Battery Concept Stock with Market Value of 14 Billion Investigated | Post-Market Announcement Highlights - 富途牛牛","headline":"Breaking: Directors and Senior Executives of Solid-State Battery Concept Stock with Market Value of 14 Billion Investiga","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxOYm5ybUJwTTRNXzhld2VUVlFXOFBUYkVqbVdqSzgxdE5IbXJzQ3BkdGpPYzZpMjV4SjF3cmdKbXVXOGNYb2dGNDgtX24tZXZzS1ppbFRaM2h2emlKMDJvUkRCTnZWN29zTWpCRlJIY1kwZk03MEJHNTE0T0dibDdPUmRXSXdNMTNYcXFsdlNCOUg4ZGtFUDhYZkVvTXo1QQ?oc=5","date":"2025-11-04","type":"pipeline","source":"BioWorld News","summary":"Chinese scientists discover new GABA-A receptor agonists - BioWorld News","headline":"Chinese scientists discover new GABA-A receptor agonists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxNbG1vRV9IVGNCcmx3eXBOdUJpZzhmRWZQUzl5SW96Z0VJeDlYZG4wSndMaFlTQ2FYMURma0RZVWd3Y0djMmVJdWxYTXU2UkVGbDlacWhNaWZzRXlOX082MnJweThGMk5RWjN0VnpIWEluR1lueUxuMTZSY0NEVENTc2FQcThhZnNUSEZUZWpyZzI5NVg0SjFORE41aw?oc=5","date":"2025-09-29","type":"earnings","source":"富途牛牛","summary":"Up to 17-fold YoY increase! Solid-state battery concept stocks worth 7.8 billion release Q1-Q3 earnings forecast | Post-market announcements digest - 富途牛牛","headline":"Up to 17-fold YoY increase! Solid-state battery concept stocks worth 7.8 billion release Q1-Q3 earnings forecast | Post-","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQV2tzUmRUX3FwXzdlUTFhNXhRU2FJc0lHX2lzMXUzcWNCUUI0NU85QWVfdU9xaWNtV0pWMHRwaG5vZHRXVEo4bnN4Q1B2aVBZZl9YLU96MzhvV0lrZTdpWHlTZ3Q0TWR1RFQyVVZCV0FqMTNnWjAwbEtza1REQmFfd2pGb0Z3V3JTSFRReVp0ZS1Ic1dnMk9aS3A5eF9STVpwanV5VnB4dUhrQWVSd0t2THh3?oc=5","date":"2023-08-28","type":"patent","source":"BioWorld News","summary":"Chinese researchers patent new antibody-drug conjugates targeting IL-4R - BioWorld News","headline":"Chinese researchers patent new antibody-drug conjugates targeting IL-4R","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPVFM0ODFnZy14OXMtR1MxTjlaWmhEUXV5c0ZteFdmZVhKR0lrSGtuRlZ6VkVWRUliUnFRRVYxV3VDWEFYdjVvdTIzQ3FkQnBhbEx2NnlTUURxajBDR1JUbm5uYW9wTGZvTnhCRGNwU1A3V0NSa1pjYU03OEd5TlBkMW5NcXRKam52R1pxUjlZVUxTaW9oazMtY1hmVDN6OXpr?oc=5","date":"2023-03-14","type":"pipeline","source":"BioWorld News","summary":"China’s NMPA clears Shengdi’s adebrelimab for extensive SCLC - BioWorld News","headline":"China’s NMPA clears Shengdi’s adebrelimab for extensive SCLC","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}